PSTV/ 04/08/2026 · 8:47 AM Plus Therapeutics Stock Jumps After FDA Orphan Drug Win for Kids’ Rare Brain Tumors Plus Therapeutics’ REYOBIQ gets FDA orphan drug status for rare kids’ brain tumors.
